
QuantHealth raises $45 million Series B to bring AI simulations to the costly world of clinical trials - calcalistech.com
QuantHealth develops AI-based simulations for clinical trials, helping drugmakers test decisions before enrolling patients or committing significant capital. The company aims to improve the efficiency and success rates of clinical trials, which are often costly and uncertain.
QuantHealth raises $45 million Series B to bring AI simulations to the costly world of clinical trials calcalistech.com

| Aug 04, 2026 | Oligo Security | $60.0M | — | Israel |
| Aug 03, 2026 | Zenity | $125.0M | Series C | Israel |
| Aug 03, 2026 | Clarity | $45.0M | — | Israel |
| Aug 02, 2026 | Xsight Labs | $300.0M | — | Israel |